Treating Drosophila manipulated to express human wild-type, N370S and L444P GBA1, with IFG resulted in decreased ER stress and preserved motor function, suggesting that IFG might have potential as a PD therapy (Sanchez-Martinez et al., 2016). This evidence concerns the gene IFNG and Parkinson disease.